Qube Research & Technologies (QRT)
MRK icon

Qube Research & Technologies (QRT)’s Merck MRK Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.5M Sell
175,100
-137,400
-44% -$16.1M 0.02% 856
2026
Q1 		$37.6M Sell
312,500
-288,200
-48% -$33.3M 0.04% 542
2025
Q4 		$63.2M Sell
600,700
-523,000
-47% -$49.1M 0.06% 392
2025
Q3 		$94.3M Sell
1,123,700
-130,300
-10% -$10.7M 0.1% 251
2025
Q2 		$99.3M Buy
1,254,000
+982,000
+361% +$78.1M 0.1% 258
2025
Q1 		$24.4M Buy
272,000
+65,800
+32% +$6.14M 0.03% 663
2024
Q4 		$20.5M Buy
206,200
+95,300
+86% +$9.82M 0.03% 709
2024
Q3 		$12.6M Buy
+110,900
New +$13.2M 0.02% 903
2024
Q1 		– Sell
-25,200
Closed -$2.75M – 4727
2023
Q4 		$2.75M Sell
25,200
-38,600
-61% -$4.01M 0.01% 1365
2023
Q3 		$6.57M Buy
+63,800
New +$6.88M 0.02% 813

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MRK Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Merck (MRK) in Q2 2026: 1,044,210 shares worth $134M. The stake represents 0.12% of the portfolio and ranks #204 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in MRK as recently as Q3 2025.

Qube Research & Technologies (QRT) first reported a position in MRK in Q1 2018 and has held it in 27 quarters since. The position peaked at $529M in Q2 2024. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Qube Research & Technologies (QRT) held 1,044,210 shares of Merck worth $134M as of Q2 2026.
  • Merck was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • Merck made up 0.12% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #204 holding.
  • Qube Research & Technologies (QRT) first reported a position in Merck in Q1 2018 and has held it in 27 quarters since.
  • Qube Research & Technologies (QRT)'s Merck position peaked at $529M in Q2 2024.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.